Founded with the mission to enhance the quality of life for individuals suffering from Age-Related Macular Degeneration (AMD) and other low-vision diseases, Eyedaptic offers innovative vision solutions. Their flagship product, AdaptiVu, is a non-invasive, battery-powered wearable device designed in collaboration with leading ophthalmology retinal specialists, low vision optometrists, and occupational therapists. Utilizing proprietary vision-enhancing software, AdaptiVu simulates natural vision, making everyday tasks easier and improving overall quality of life for users.
Eyedaptic has garnered attention from notable medical experts and investors due to its groundbreaking approach to vision enhancement. The company’s key achievements include the development of the Eyedaptic EYE5, a best-in-class solution that optimizes the user’s field of vision with patent-pending software. Eyedaptic's impact is significant, providing AMD sufferers and those with low vision a practical tool to regain visual functionality and independence, thereby revitalizing their lives.
